Advances in B Cell Biology:
RA, SLE, and Vasculitis
Saturday, February 18, 2012
Gainey Ranch Golf Club
Scottsdale, Arizona
Registration - This event is complimentary
Description
Recent research efforts have increasingly focused on the efficacy, utility, and safety of B cell-targeted therapies for autoimmune rheumatic diseases (ARDs) including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and vasculitis. The increasing adoption of these targeted biologic agents into clinical practice challenges clinicians to remain informed regarding data from new and ongoing research studies and clinical trials, especially those presented at national and international meetings.
Advances in B Cell Biology: RA, SLE, and Vasculitis is a CME-accredited activity in which expert faculty bridge the gap between the complexities of current immunologic data and how they can be incorporated into clinical practice. It is designed for busy clinicians interested in keeping abreast of cutting-edge data and novel therapies in treatment of ARDs – information that can have significant positive impacts on patient outcomes.
Target Audience
This symposium is directed to rheumatologists, immunologists, allied health professionals, and other health care professionals interested in rheumatic diseases.
Objectives
As a result of attending this symposium, the
participant will be able to do the following:
- Summarize recent findings on B cell
biology as they apply to understanding
the pathophysiology of autoimmune and
inflammatory diseases and describe how
this knowledge has influenced the development
of new and innovative therapeutics utilizing
these pathways;
- Describe recent clinical trial data on the
efficacy and safety of biologic therapeutics
targeting B cell pathways in patients with RA;
- Describe the role of B cells in the pathogenesis
of SLE and assess data from recent clinical
trials of biologic therapeutics that target
these pathways;
- Describe the role of B cells in the pathogenesis of systemic vasculitis and appraise recent clinical trial data on the efficacy and toxicity of traditional and biologic therapies.
Directors
| Leonard Calabrese, DO Professor of Medicine Cleveland Clinic Lerner College of Medicine of Case Western Reserve University R.J. Fasenmyer Chair of Clinical Immunology Vice Chairman Department of Rheumatic and Immunologic Diseases Orthopaedic and Rheumatologic Institute Cleveland Clinic Cleveland, OH |
Gregg J. Silverman, MD Co-Director Musculoskeletal Center New York University School of Medicine Smilow Research Center New York, NY |
Faculty
Richard Furie, MD Jonathan Kay, MD |
William Rigby, MD |
Agenda
| SATURDAY, FEBRUARY 18, 2012 | |
| 8:00 am | Registration and Continental Breakfast |
| 8:20 am | Welcome and Introduction |
| 8:30 am | New Perspectives on B Cell Immunobiology and Emerging B Cell Therapies - Gregg Silverman, MD |
| 9:15 am | Advances in B Cell Therapy for RA - William Rigby, MD |
| 9:45 am | Advances in B Cell-Directed Therapies in SLE - Richard Furie, MD |
| 10:15 am | Refreshment Break |
| 10:30 am | Emerging Role of B Cell-Directed Therapies for Vasculitis - Leonard Calabrese, DO |
| 11:00 am | Safety in Biologics - Jonathan Kay, MD |
| 11:30 am | Advances in B Cell Biology – Interactive Case Discussion Panel |
| 12:00 pm | Adjourn |
Location
Gainey Ranch Golf Club
7600 Gainey Club Drive,
Scottsdale, Arizona
Phone: 480.951.0022
Website: www.gaineyranchcc.com
View Larger Map |
Hotel Accommodations
A block of rooms has been reserved at the Gainey Suites Hotel. To make your reservations, contact the Hotel Reservations Department at 800.970.4666. Identify yourself as being with the Advances in B Cells Conference for a special rate of $179 studio king suite; $189 for one bedroom king or queen suite.
Additional Information
For further information about the course, contact Cleveland Clinic Center for Continuing Education at:
Local: 216.448.0770
Toll Free: 800.238.6750
For questions about registering online, call 216.448.0777 or email CMEregistration@ccf.org.
Faculty Disclosure
The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.
Americans with Disabilities Act
The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify us at least two weeks prior to the activity.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Online Registration/Fees
| Category | Full Event |
|---|---|
| All Attendees | complimentary |
